Effects of antiphospholipid antibodies on in vitro platelet aggregation

Clinical and Applied Thrombosis/Hemostasis

Volumn 18, Issue 1, 2012, Pages 59-65

  Palatinus, Anita A ^a   Ahuja, Kiran D K ^a   Adams, Murray J ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

aggregation; anti 2GP1; antiphospholipid antibody; platelets; thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA2 GLYCOPROTEIN 1; COLLAGEN; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

AGONIST; ANTIBODY AFFINITY; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOGENESIS;

ADENOSINE DIPHOSPHATE; ANTIBODIES, ANTIPHOSPHOLIPID; BLOOD PLATELETS; COLLAGEN; FEMALE; HUMANS; MALE; PLATELET AGGREGATION; THROMBOSIS;

EID: 84857531966     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029611412360     Document Type: Article

References (22)

1. Rand JH.. The antiphospholipid syndrome. Annu Rev Med. 2003 ; 54: 409-424
2. Durrani OM, Gordon C, Murray PI.. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol. 2002 ; 47 (3). 215-238
3. Adams M, Breckler L, Stevens P, Thom J, Baker R, Oostryck R.. Anti-tissue factor pathway inhibitor activity in subjects with antiphospholipid syndrome is associated with increased thrombin generation. Haematologica. 2004 ; 89 (8). 985-990
4. Adams MJ, Donohoe S, Mackie IJ, Machin SJ.. Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome. Br J Haematol. 2001 ; 114 (2). 375-379
5. Palomo IG, Segovia FM, Alarcon ML, et al. An insight into the pathophysiology of thrombosis in antiphospholipid syndrome. Front Biosci. 2007 ; 12: 3093-3103
6. Palatinus A, Adams M.. Thrombosis in systemic lupus erythematosus. Semin Thromb Haemost. 2009 ; 35 (7). 621-629
7. Amengual O, Atsumi T, Khamashta MA, Hughes GR.. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost. 1998 ; 79 (2). 276-281
8. Dhar JP, Andersen J, Essenmacher L, Ager J, Bentley G, Sokol RJ.. Thrombophilic patterns of coagulation factors in lupus. Lupus. 2009 ; 18 (5). 400-406
9. Lin YL, Wang CT.. Activation of human platelets by the rabbit anticardiolipin antibodies. Blood. 1992 ; 80 (12). 3135-3143
10. Tokita S, Arai M, Yamamoto N, et al. Specific cross-reaction of IgG anti-phospholipid antibody with platelet glycoprotein IIIa. Thromb Haemost. 1996 ; 75 (1). 168-174
11. Orlando E, Cortelazzo S, Marchetti M, Sanfratello R, Barbui T.. Prolonged bleeding time in patients with lupus anticoagulant. Thromb Haemost. 1992 ; 68 (5). 495-509
12. Urbanus R, de Laat H, de Groot P, Derksen R.. Prolonged bleeding time and lupus anticoagulant: a second paradox in the antiphospholipid syndrome. Arthritis Rheum. 2004 ; 50 (11). 3605-3609
13. Ahuja KD, Adams MJ, Robertson IK, Ball MJ.. Acute effect of a high-carbohydrate low-fat meal on platelet aggregation. Platelets. 2009 ; 20 (8). 606-609
14. Jin J, Kunapuli SP.. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci U S A. 1998 ; 95 (14). 8070-8074
15. Vickers JD, Kinlough-Rathbone RL, Mustard JF.. The decrease in phosphatidylinositol 4,5-bisphosphate in ADP-stimulated washed rabbit platelets is not primarily due to phospholipase C activation. Biochem J. 1986 ; 237 (2). 327-332
16. Vickers JD, Kinlough-Rathbone RL, Packham MA, Mustard JF.. Inositol phospholipid metabolism in human platelets stimulated by ADP. Eur J Biochem. 1990 ; 193 (2). 521-528
17. Nimpf J, Wurm H, Kostner GM.. Beta 2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis. 1987 ; 63 (2-3). 109-114
18. Nieswandt B, Watson SP.. Platelet-collagen interaction: is GPVI the central receptor?. Blood. 2003 ; 102 (2). 449-461
19. Lutters B, Derksen R, Tekelenburg W, Lenting P, Arnout J, de Groot P.. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2. J Biol Chem. 2003 ; 278 (36). 33831-33838
20. Jankowski M, Vreys I, Wittevrongel C, et al. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood. 2003 ; 101 (1). 157-162
21. Lean S, Ellery P, Ivey L, et al. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation. Haematologica. 2006 ; 91 (10). 1360-1366
22. De Laat H, Derksen R, Urbanus R, Roest M, De Groot P.. Beta2-glycoprotein I-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood. 2004 ; 104 (12). 3598-3602